---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-011752"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:14:33.290611+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NextCure CSO resigns effective Sept 1, 2025; no replacement named

## Summary
- Solomon Langermann, Ph.D., resigned as Chief Scientific Officer, effective September 1, 2025.
- Resignation was not due to any disagreement with the Company or its operations.
- No successor has been announced at this time.
- Board and Company thanked Dr. Langermann for his contributions.

## SEC filing metadata
- accession: 0001558370-25-011752
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/0001558370-25-011752-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837025011752/nxtc-20250821x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-011752
- JSON: https://secwatch.observer/filing/0001558370-25-011752.json
- Plain text: https://secwatch.observer/filing/0001558370-25-011752.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.